Pros and cons of subcutaneous (SC) versus intravenous (IV) administration of immune checkpoint inhibitors in non-small cell lung cancer
@article{TLCR87273,
author = {Julie Moeller and Michael D. Green and Nithya Ramnath},
title = {Pros and cons of subcutaneous (SC) versus intravenous (IV) administration of immune checkpoint inhibitors in non-small cell lung cancer},
journal = {Translational Lung Cancer Research},
volume = {13},
number = {6},
year = {2024},
keywords = {},
abstract = {},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/87273}
}